International Patent: ANTI-OLIGOMERIC AMYLOID BETA ANTIBODY VARIANT AND METHODS OF USE THEREOF

GENEVA, Aug. 7 -- ACUMEN PHARMACEUTICALS, INC. filed a patent application (US2026/012616) for “ANTI-OLIGOMERIC AMYLOID BETA ANTIBODY VARIANT AND METHODS OF USE THEREOF”. With publication no. WO/2026/164979, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....